Skip to main content
. 2018 Mar 2;16:42. doi: 10.1186/s12957-018-1349-y

Fig. 4.

Fig. 4

Kaplan-Meier curves of overall survival in LZTS2 promoter hypomethylated and hypermethylated LSCC patients. Log-rank test results indicated that LSCC patients with LZTS2 hypermethylated promoters (n = 37) had significantly worse overall survival rates than those who had LZTS2 hypomethylated promoters (n = 59) (P = 0.028)